Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI

Mutations in the liver glycogen phosphorylase (Pygl) gene are associated with the diagnosis of glycogen storage disease type VI (GSD‐VI). To understand the pathogenesis of GSD‐VI, we generated a mouse model with Pygl deficiency (Pygl−/−). Pygl−/− mice exhibit hepatomegaly, excessive hepatic glycogen...

Full description

Bibliographic Details
Main Authors: Lane H. Wilson, Jun‐Ho Cho, Ana Estrella, Joan A. Smyth, Rong Wu, Tayoot Chengsupanimit, Laurie M. Brown, David A. Weinstein, Young Mok Lee
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2019-11-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1426
_version_ 1797713725304602624
author Lane H. Wilson
Jun‐Ho Cho
Ana Estrella
Joan A. Smyth
Rong Wu
Tayoot Chengsupanimit
Laurie M. Brown
David A. Weinstein
Young Mok Lee
author_facet Lane H. Wilson
Jun‐Ho Cho
Ana Estrella
Joan A. Smyth
Rong Wu
Tayoot Chengsupanimit
Laurie M. Brown
David A. Weinstein
Young Mok Lee
author_sort Lane H. Wilson
collection DOAJ
description Mutations in the liver glycogen phosphorylase (Pygl) gene are associated with the diagnosis of glycogen storage disease type VI (GSD‐VI). To understand the pathogenesis of GSD‐VI, we generated a mouse model with Pygl deficiency (Pygl−/−). Pygl−/− mice exhibit hepatomegaly, excessive hepatic glycogen accumulation, and low hepatic free glucose along with lower fasting blood glucose levels and elevated blood ketone bodies. Hepatic glycogen accumulation in Pygl−/− mice increases with age. Masson's trichrome and picrosirius red staining revealed minimal to mild collagen deposition in periportal, subcapsular, and/or perisinusoidal areas in the livers of old Pygl−/− mice (>40 weeks). Consistently, immunohistochemical analysis showed the number of cells positive for alpha smooth muscle actin (α‐SMA), a marker of activated hepatic stellate cells, was increased in the livers of old Pygl−/− mice compared with those of age‐matched wild‐type (WT) mice. Furthermore, old Pygl−/− mice had inflammatory infiltrates associated with hepatic vessels in their livers along with up‐regulated hepatic messenger RNA levels of C‐C chemokine ligand 5 (Ccl5/Rantes) and monocyte chemoattractant protein 1 (Mcp‐1), indicating inflammation, while age‐matched WT mice did not. Serum levels of aspartate aminotransferase and alanine aminotransferase were elevated in old Pygl−/− mice, indicating liver damage. Conclusion: Pygl deficiency results in progressive accumulation of hepatic glycogen with age and liver damage, inflammation, and collagen deposition, which can increase the risk of liver fibrosis. Collectively, the Pygl‐deficient mouse recapitulates clinical features in patients with GSD‐VI and provides a model to elucidate the mechanisms underlying hepatic complications associated with defective glycogen metabolism.
first_indexed 2024-03-12T07:41:03Z
format Article
id doaj.art-eb094ee5286e491c88069ed9a8d697ac
institution Directory Open Access Journal
issn 2471-254X
language English
last_indexed 2024-03-12T07:41:03Z
publishDate 2019-11-01
publisher Wolters Kluwer Health/LWW
record_format Article
series Hepatology Communications
spelling doaj.art-eb094ee5286e491c88069ed9a8d697ac2023-09-02T21:19:00ZengWolters Kluwer Health/LWWHepatology Communications2471-254X2019-11-013111544155510.1002/hep4.1426Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VILane H. Wilson0Jun‐Ho Cho1Ana Estrella2Joan A. Smyth3Rong Wu4Tayoot Chengsupanimit5Laurie M. Brown6David A. Weinstein7Young Mok Lee8Glycogen Storage Disease Program Department of Pediatrics University of Connecticut School of Medicine Farmington CTGlycogen Storage Disease Program Department of Pediatrics University of Connecticut School of Medicine Farmington CTGlycogen Storage Disease Program Department of Pediatrics University of Connecticut School of Medicine Farmington CTConnecticut Veterinary Medical Diagnostic Laboratory Department of Pathobiology and Veterinary Science University of Connecticut Storrs CTBiostatistics Center Connecticut Convergence Institute for Translation in Regenerative Engineering University of Connecticut Health Center Farmington CTGlycogen Storage Disease Program University of Florida College of Medicine Gainesville FLGlycogen Storage Disease Program University of Florida College of Medicine Gainesville FLGlycogen Storage Disease Program Department of Pediatrics University of Connecticut School of Medicine Farmington CTGlycogen Storage Disease Program Department of Pediatrics University of Connecticut School of Medicine Farmington CTMutations in the liver glycogen phosphorylase (Pygl) gene are associated with the diagnosis of glycogen storage disease type VI (GSD‐VI). To understand the pathogenesis of GSD‐VI, we generated a mouse model with Pygl deficiency (Pygl−/−). Pygl−/− mice exhibit hepatomegaly, excessive hepatic glycogen accumulation, and low hepatic free glucose along with lower fasting blood glucose levels and elevated blood ketone bodies. Hepatic glycogen accumulation in Pygl−/− mice increases with age. Masson's trichrome and picrosirius red staining revealed minimal to mild collagen deposition in periportal, subcapsular, and/or perisinusoidal areas in the livers of old Pygl−/− mice (>40 weeks). Consistently, immunohistochemical analysis showed the number of cells positive for alpha smooth muscle actin (α‐SMA), a marker of activated hepatic stellate cells, was increased in the livers of old Pygl−/− mice compared with those of age‐matched wild‐type (WT) mice. Furthermore, old Pygl−/− mice had inflammatory infiltrates associated with hepatic vessels in their livers along with up‐regulated hepatic messenger RNA levels of C‐C chemokine ligand 5 (Ccl5/Rantes) and monocyte chemoattractant protein 1 (Mcp‐1), indicating inflammation, while age‐matched WT mice did not. Serum levels of aspartate aminotransferase and alanine aminotransferase were elevated in old Pygl−/− mice, indicating liver damage. Conclusion: Pygl deficiency results in progressive accumulation of hepatic glycogen with age and liver damage, inflammation, and collagen deposition, which can increase the risk of liver fibrosis. Collectively, the Pygl‐deficient mouse recapitulates clinical features in patients with GSD‐VI and provides a model to elucidate the mechanisms underlying hepatic complications associated with defective glycogen metabolism.https://doi.org/10.1002/hep4.1426
spellingShingle Lane H. Wilson
Jun‐Ho Cho
Ana Estrella
Joan A. Smyth
Rong Wu
Tayoot Chengsupanimit
Laurie M. Brown
David A. Weinstein
Young Mok Lee
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
Hepatology Communications
title Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
title_full Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
title_fullStr Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
title_full_unstemmed Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
title_short Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI
title_sort liver glycogen phosphorylase deficiency leads to profibrogenic phenotype in a murine model of glycogen storage disease type vi
url https://doi.org/10.1002/hep4.1426
work_keys_str_mv AT lanehwilson liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT junhocho liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT anaestrella liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT joanasmyth liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT rongwu liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT tayootchengsupanimit liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT lauriembrown liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT davidaweinstein liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi
AT youngmoklee liverglycogenphosphorylasedeficiencyleadstoprofibrogenicphenotypeinamurinemodelofglycogenstoragediseasetypevi